HTLV infection in a group of prostitutes and their male sexual clients in Brazil: Seroprevalence and risk factors

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 1996, Pages 122-125

  Bellei, N C J ^a   Granato, C F H ^a   Tomyiama, H ^a   Castelo, A ^a   Ferreira, O ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Htlv; Prostitutes and clients; Risk factors; Seroprevalence

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; BRAZIL; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; MALE; PROSTITUTION; RISK FACTOR; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0029874958     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90107-8     Document Type: Article

References (28)

1. Berger, J. R., Svenningsson, A., Raffanti, S. & Resnick, L. (1991). Tropical spastic paraparesis-like syndrome occuring in a patient dually infected with HIV-1 and HTLV-II. Neurology, 41, 85-87.
2. Blumer, S. O., Hearn, T. L., Schalla, W. O., Cross, G. D. & Valdiserri, R. O. (1992). Human T-lymphotropic virus type I/II: status of enzyme immunoassay and Western blot testing in the United States in 1989 and 1990. Archives of Pathology and Laboratory Medicine, 116, 471-476.
3. Bush, M. P., Laycock, M., Kleinman, S. H., Wages, J. W., jr, Calabro, M., Kaplan, J. E., Khabbaz, R. F., Hollingsworth, C. G. & the Retrovirus Epidemiology Donor Study (1994). Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Blood, 83, 1143-1148,
4. Carvalho, S. M. F., Oliveira, M. S. P., Pereira, J. M., Reis, A. M., Guadagnino, M. C. & Azevedo, J. G. (1994). Infection states of HTLV-I/II in Rio de Janeiro: data of two centers. AIDS Research and Human Retroviruses, 10, 493
5. CDC [Centers for Disease Control] (1989). Licensure of screening tests for antibody to human T-lymphotropic virus type 1. Journal of the American Medical Association, 261, 513-525.
6. CDC [Centers for Disease Control] and the USPHS Working Group (1993). Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Annals of Internal Medicine, 118, 448-454.
7. Cleghorn, F. R. & Blattner, W. A. (1992). Does human T-cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? Archives of Internal Medicine, 152, 1372-1375.
8. Dixon, W. J. (editor) (1990). Statistical Software Manual. Berkeley: University of California Press.
9. Erlich, G. D., Glaser, J. B., La Vingne, K., Quan, D., Mildvan, D., Sninsky, J. J., Kwok, S., Papsidero, L. & Poiesz, B. J. (1989). Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood, 74, 1658-1664.
10. Granato, C., Castelo, A., Waldman, E. A., Gerbi, L., Zamarioli, L., Lorenço, R. & Johnson, W. D., jr (1992). Occurrence of HIV-1 and HIV-2 in Brazil. Journal of the Acquired Immune Deficiency Syndrome, 6, 531-532.
11. Hjelle, B., Cyrus, S., Swenson, S. & Mills, R. (1991). Serologic distinction between human T-lymphotropic virus (HTLV) type I and HTLV type II. Transfusion, 31, 731-736.
12. Jacobson, S., Lehky, T., Nishimura, M., Robinson, S., McFarlin, D. & Dhib-Jalbut, S. (1993). Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/ tropical spastic paraparesis. Annnals of Neurology, 33, 392-396.
13. Kalyanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, M., Miyoshi, I., Blayney, D., Golde, D. & Gallo, R. C. (1982). A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science, 218, 571-573.
14. Khabbaz, R. F., Darrow, W. W., Hartley, T. M., Witte, J., Cohen, J. B., French, J., Gill, P. S., Potterat, J., Sikes, K., Reich, R., Kaplan, J. E. & Lairmore, M. D. (1990). Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. Journal of the American Medical Association, 263, 60-64.
15. Khabbaz, R. F., Hartel, D., Lairmore, M., Horsburgh, C. R., Schoenbaum, B. R., Hartley, T. M. & Friedland, G. (1991). Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? Journal of Infectious Diseases, 163, 252-256.
16. Lal, R. B., Heneine, W., Rudoph, D. L., Present, W. B., Hofhienz, D., Hartley, T. M., Khabbaz, R. F. & Kaplan, J. E. (1992). Synthetic peptide-based immunoassays for distinguishing between human T-cell leukemia in Blacks from the West Indies. Lancet, i, 639-643.
17. Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D. & Chen, I. S. (1989). High rate of HTLV-II infection in seropositive intravenous drug abusers in New Orleans. Science, 244, 471-475.
18. Loughran, T. P., jr, Sherman, M. P., Rusceti, F. W., Frey, S., Coyle, T., Montagna, R. A., Jones, B., Starkenbaum, G. & Poiesz, B. J. (1994). Prototypical HTLV-I/II infection is rare in LGL leukemia. Leukemia Research, 18, 423-439.
19. Manns, A. & Blattner, W. A. (1991). The epidemiology of the human T-cell lymphotropic virus type I and type II: etiologic role in human disease. Transfusion, 31, 67-75.
20. Matutes, E., Schulz, T., Andrada-Serpa, M. J., Araulo, A. & Pombo De Oliveira, M. S. (1994). Report of second international symposium on HTLV in Brazil. Leukemia, 8, 1092-1094.
21. Murphy, E. L., Engstrom, J. W., Miller, K., Sacher, R. A., Busch, M. P. & Hollingsworth, C. G. (1993). HTLV-II associated myeolopathy in a 43-year-old woman. Lancet, 341, 757-758.
22. Palker, T. J., Searce, R. M., Ho, W., Copeland, T. D., Oroszlan, S., Popovic, M. & Haynes, B. F. (1985). Monoclonal antibodies reactive with human T cell lymphotropic virus (HTLV-I) p19 internal core protein: cross reactivity with normal tissues and differential reactivity with HTLV types I and II. Journal of Immunology, 135, 247-254.
23. Pombo De Oliveira, M. S., Matutcs, E., Famadas, L. C., Schulz, T. F., Calabro, M. L., Nucci, M., Andrada-Serpa, M. J., Tedder, R. S., Weiss, R. A. & Catovsky, D. (1990). Adult T-cell leukemia/lymphoma in Brazil and its relation to HTLV-I. Lancet, 336, 987-990.
24. Quesada, J. R., Reuben, J. M., Hopfer, R. L., Mundon, F. & Hersch, E. M. (1986). Serologic studies in hairy cell leukemia: high prevalence of Epstein-Barr and cytomegalovirus antibodies and absence of human T-cell lymphotropic virus antibodies. Leukemia Research, 10, 1169-1173.
25. Rosenblatt, J. D., Gasson, J. C., Glapsy, J., Bhuta, S., Aboud, M., Chen, I. S. & Golde, D. W. (1987). Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients. Leukemia, 1, 397-401.
26. Viera, J. G. H., Nishida, S., Silva, S. M., Gomez-Ferraz, M. L. C. & Granato, C. F. H. (1988). Production of anti-HBsAg monoclonal antibodies. Brazilian Journal of Medical and Biological Research, 21, 507-509.
27. WHO (1990). Recommendations for the interpretation of HIV-2 Western-blot results. Bulletin of the World Health Organization, 68, 515.
28. Yodoi, J. & Uchiyama, T. (1992). Diseases associated with HTLV-I virus, IL-2 receptor dysregulation and redox regulation. Immunology Today, 13, 405-411.